It would be logical to assume that high baseline circulating TGF-β would be linked with poor responses, but it may be a signal that the immune system is actively trying to attack the tumour, which is protected by TGF-β as inflammatory and immunoregulatory responses are closely coordinated and can be tipped towards success by ICI. Here, TGFB1 is linked to neoplasm.